These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 1412875)

  • 21. Optimal combination of immunosuppressive agents for renal transplantation: first report of a multicentre, randomised trial comparing cyclosporine+prednisolone with cyclosporine+azathioprine and with triple therapy in cadaver renal transplantation. The Australian Collaborative Trials Committee.
    Hardie IR; Tiller DJ; Mahony JF; Miach PJ; Thomson NM; Thatcher GN; Rigby RJ; Menzies BL
    Transplant Proc; 1993 Feb; 25(1 Pt 1):583-4. PubMed ID: 8438424
    [No Abstract]   [Full Text] [Related]  

  • 22. Is sensitivity to cyclosporine influenced by the HLA-DR phenotype of kidney graft recipients?
    Kyriakopoulos G; Antoniadis A; Gakis D; Papanikolaou V
    Transplant Proc; 1996 Dec; 28(6):3294-5. PubMed ID: 8962278
    [No Abstract]   [Full Text] [Related]  

  • 23. Effects of azathioprine, cyclosporine, and steroids on the graft and on cytologic patterns of rejection.
    Häyry P; von Willebrand E; Ahonen J; Eklund B; Salmela K; Höckerstedt K; Pettersson E; Koskimies S
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1650-1. PubMed ID: 3079031
    [No Abstract]   [Full Text] [Related]  

  • 24. A controlled prospective trial of triple therapy with low-dose azathioprine, cyclosporine, and methylprednisolone in renal transplantation.
    De Vecchi A; Tarantino A; Montagnino G; Egidi F; Vegeto A; Berardinelli L; Ponticelli C
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1933-4. PubMed ID: 3079060
    [No Abstract]   [Full Text] [Related]  

  • 25. Long-term results with conversion from cyclosporine to azathioprine at 3 months after renal transplantation.
    Ovnat A; Pontin AR; Cassidy MJ; Swanepoel CR; Kahn D
    Transplant Proc; 1992 Oct; 24(5):1698-9. PubMed ID: 1412802
    [No Abstract]   [Full Text] [Related]  

  • 26. Prophylactic OKT3, CyA, and steroids versus antilymphoblast globulin, CyA, and steroids in cadaveric kidney transplantation.
    Griñó JM; Castelao AM; Serón D; Gonzalez C; Galceran JM; Gil-Vernet S; Andrés E; Bover J; Torras J; Alsina J
    Transplant Proc; 1992 Feb; 24(1):39-41. PubMed ID: 1539329
    [No Abstract]   [Full Text] [Related]  

  • 27. Cytokine-release syndrome: differences between high and low doses of OKT3.
    Norman DJ; Kimball JA; Barry JM
    Transplant Proc; 1993 Apr; 25(2 Suppl 1):35-8. PubMed ID: 8465420
    [No Abstract]   [Full Text] [Related]  

  • 28. Detrimental effects of cyclosporin A on long-term graft survival in familial Mediterranean fever renal allograft recipients: experience of two transplantation centers.
    Shabtai M; Ben-Haim M; Zemer D; Malinger-Saavedra P; Rosin D; Kuriansky J; Lustig S; Shabtai EL; Shapira Z; Ayalon A
    Isr Med Assoc J; 2002 Nov; 4(11 Suppl):935-9. PubMed ID: 12455184
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Five-year experience with a triple drug protocol in renal transplantation.
    Pallardó LM; Sánchez J; García J; Puig N; Sánchez P; Górriz JL; Cruz JM
    Transplant Proc; 1992 Feb; 24(1):56-7. PubMed ID: 1539342
    [No Abstract]   [Full Text] [Related]  

  • 30. Corticosteroid withdrawal with substitution of azathioprine in cyclosporine-treated primary cadaveric renal transplant recipients.
    Kupin W; Venkat KK; Florence-Green D; Norris C; Oh HK; Dienst S; Levin NW
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2024-6. PubMed ID: 3274465
    [No Abstract]   [Full Text] [Related]  

  • 31. Immunosuppression for recipients of kidneys from non-heart-beating donors: comparison of triple therapy and OKT3 regimens.
    Kehinde EO; Wheatley T; Feehally J; Nicholson ML; Veitch PS; Bell PR
    Transplant Proc; 1996 Jun; 28(3):1338-9. PubMed ID: 8658684
    [No Abstract]   [Full Text] [Related]  

  • 32. Retrospective study of cyclosporine-prednisolone versus cyclosporine-azathioprine-prednisolone immunosuppression in living donor kidney transplantation.
    Reissi D; Bardideh A; Samadzadeh B; Razi A
    Transplant Proc; 1995 Oct; 27(5):2685-6. PubMed ID: 7482875
    [No Abstract]   [Full Text] [Related]  

  • 33. Long-term outcome after switch from cyclosporine-based triple-drug immunosuppression to double therapy at three months.
    Aichberger C; Eberl T; Riedmann B; Pernthaler H; Ofner D; Königsrainer A; Margreiter R
    Clin Transplant; 1996 Apr; 10(2):209-12. PubMed ID: 8664521
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monitoring of donor sensitization in kidney transplant recipients by flow cytometric crossmatch.
    Cinti P; Bachetoni A; Baiano V; Pretagostini R; Poli L; Berloco P; Renna Molajoni E; Cortesini R
    Transplant Proc; 1993 Dec; 25(6):3265-6. PubMed ID: 8266536
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of anti-IL-2-receptor monoclonal antibody BT 563 in treatment of acute interstitial renal rejection.
    Carl S; Wiesel M; Daniel V; Staehler G
    Transplant Proc; 1995 Feb; 27(1):854-5. PubMed ID: 7879205
    [No Abstract]   [Full Text] [Related]  

  • 36. Importance of cyclosporine dosage and blood levels in simultaneous pancreas and kidney transplant success.
    Cantarovich D; Dantal J; Hourmant M; Baatard R; Paineau J; Murat A; Soulillou JP
    Transplant Proc; 1992 Jun; 24(3):890-1. PubMed ID: 1604657
    [No Abstract]   [Full Text] [Related]  

  • 37. Renal transplant artery thrombosis following treatment of allograft rejection with monoclonal anti-CD3 antibodies (OKT3).
    Noël C; Hazzan M; Coppin MC; Pruvot FR; Bridoux F; Lelièvre G
    Transplant Proc; 1995 Aug; 27(4):2438-9. PubMed ID: 7652870
    [No Abstract]   [Full Text] [Related]  

  • 38. Problems with immunosuppression in developing countries.
    Rizvi A; Naqvi A; Hussain I; Hafeez S; Yazdani I; Hussain Z; Hashmi A; Hussain M; Askari H
    Transplant Proc; 1991 Aug; 23(4):2204-5. PubMed ID: 1871844
    [No Abstract]   [Full Text] [Related]  

  • 39. [Value of a powerful initial immunosuppression after liver transplantation. Prospective study of 60 cases].
    Cherqui D; Duvoux C; Charlotte F; Humeres R; Lauzet JY; Métreau JM; Salvat A; Rotman N; Julien M; Fagniez PL
    Gastroenterol Clin Biol; 1994; 18(2):115-22. PubMed ID: 8013792
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-interleukin 2 monoclonal antibody following simultaneous pancreatic and kidney transplantation: a randomized trial vs rabbit antithymocyte globulin.
    Cantarovich D; Hourmant M; Dantal J; Baatard R; Le Mauff B; Jacques Y; Paineau J; Murat A; Soulillou JP
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1366. PubMed ID: 8442143
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.